Camurus Appoints CMO
This article was originally published in Scrip
Swedish research-based company, Camurus, has appointed Richard Jameson chief commercial officer and member of the executive management team. Jameson has held commercial roles in various pharmaceutical companies including Schering Plough, Ferring and Indivior, where for the last three years he has been serving as Area Director EMEA.
You may also be interested in...
How to make the most of the wealth of raw data in pharmaceutical R&D is an increasing challenge for the industry. The digital revolution is already having an impact in areas like clinical trials, and pharma is also starting to embrace new technologies in drug discovery.
Technology advancement has brought a wave of change in healthcare, with an increasing number of key pharma players now recognizing the potential of digital – particularly in clinical trials.
This week's roundup includes high-level appointments by Five Prime Therapeutics, Depomed and Gilead Sciences and board appointments by Verseon, Arix Bioscience, and Corbus Pharmaceuticals.